Mephenon

Methadone Hydrochloride, the active ingredient in Mephenon, is a synthetic opioid presented as an injectable solution for intramuscular and intravenous use. It is employed in the management of opioid dependence and for the relief of severe pain in adult patients.

GNH USA supplies Mephenon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution. Customers benefit from reliable supply chains and responsive technical support.

Methadone Hydrochloride is a synthetic opioid used in opioid dependence management and severe pain control.

- Opioid dependence treatment: reduces withdrawal symptoms and cravings during maintenance therapy. - Severe pain: provides long‑acting analgesia for chronic or cancer‑related pain. - Detoxification: assists in supervised opioid tapering during detox programs.

Methadone Hydrochloride may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: occasional upset stomach or vomiting. - Constipation: reduced bowel movements, often requiring laxatives. - Drowsiness: increased sleepiness or fatigue. - Sweating: excessive perspiration, especially at night.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - QT interval prolongation: cardiac rhythm changes that may lead to arrhythmia. - Adrenal insufficiency: reduced cortisol production causing fatigue and hypotension.

When using Methadone Hydrochloride, careful clinical monitoring and adherence to safety measures are essential.

- Dose titration: adjust based on clinical response and tolerance. - Monitoring: regular assessment of respiratory function and ECG for QT prolongation. - Contraindications: avoid in patients with significant respiratory depression or untreated severe asthma. - Pregnancy: use only if benefit outweighs risk; consult a specialist. - Drug interactions: review concomitant CNS depressants and QT‑prolonging agents. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Methadone Hydrochloride interacts with several medication classes; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Concomitant opioids or CNS depressants: risk of profound respiratory depression. - QT‑prolonging drugs (e.g., quinidine, haloperidol): additive risk of arrhythmia. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase methadone plasma levels.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce efficacy. - Selective serotonin reuptake inhibitors: potential for serotonin syndrome. - Alcohol: enhances sedative effects and may impair respiration.